Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to NAV Vectors
/
Date29 Nov 2016
CAMBRIDGE, Mass., and ROCKVILLE, Md., Nov. 29, 2016 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe... Read More →
Meta Financial Group, Inc. ® Declares Cash Dividend
/
Date29 Nov 2016
SIOUX FALLS, S.D., Nov. 29, 2016 (GLOBE NEWSWIRE) — Meta Financial Group, Inc.® (NASDAQ:CASH) (the “Company”) announced that the Company will pay a cash dividend... Read More →
STEALTHGAS INC. Reports Third Quarter 2016 Financial and Operating Results
/
Date29 Nov 2016
ATHENS, Greece, Nov. 29, 2016 (GLOBE NEWSWIRE) — STEALTHGAS INC. (NASDAQ:GASS), a ship-owning company primarily serving the liquefied petroleum gas (LPG) sector of the international... Read More →
Dimension Therapeutics Receives Positive Opinion for European Orphan Drug Designation of DTX401 for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
/
Date29 Nov 2016
CAMBRIDGE, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) — Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the liver,... Read More →
Satya Nadella: Microsoft Surface Phone Will Be the ‘Ultimate Mobile Device’
/
Date29 Nov 2016
InvestorPlace InvestorPlace – Stock Market News, Stock Advice & Trading Tips Microsoft Corporation ( MSFT ) is not giving up on its Windows phone. Far... Read More →
Customers Bancorp, Inc. Targets 2018 Earnings Per Share of $3.00 as It Prepares to Cross $10 Billion Threshold
/
Date29 Nov 2016
WYOMISSING, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) — Customers Bancorp, Inc. (NYSE:CUBI), the parent company of Customers Bank (collectively referred to as “Customers” or the... Read More →
Pilgrim’s Pride Strengthens Branded Portfolio with Agreement to Purchase GNP Company
/
Date29 Nov 2016
Complementary production geographies and portfolio of on-trend brands Acquisition expected to be immediately accretive to EPS and provide annual synergies of $20 Million GREELEY, Colo.,... Read More →
OncoMed Presents Initial First-in-Human Data for Anti-DLL4/VEGF Bispecific and Anti-RSPO3 at the 28th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
/
Date29 Nov 2016
Partial Responses and Stable Disease Achieved with Bispecific as a Single-Agent Safety and Target Engagement Established for Anti-RSPO3 REDWOOD CITY, Calif., Nov. 29, 2016 (GLOBE... Read More →
Global Automotive Heads-up Display (HUD) Market to grow at a CAGR of 21.68% between 2016 and 2021: Zion Market Research
/
Date29 Nov 2016
Sarasota, FL, Nov. 29, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “Global Automotive Heads-up Display (HUD) Market (Combiner-projected HUD’s, Windshield-projected... Read More →
Bioblast Pharma Reports Third Quarter 2016 Financial Results
/
Date29 Nov 2016
TEL AVIV, Israel, Nov. 29, 2016 (GLOBE NEWSWIRE) — Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the... Read More →